Connecticut’s Healthcare Cabinet has been working on
recommendations to stem the rising costs of prescription drugs in our state.
The Chartbook
on CT Health Spending, based on newly released data from CMS actuaries, per
person drug costs for CT residents are the second highest in the nation and
rising at the third highest rate among states. And drug costs show no signs of
slowing. Just this week, several
drug makers announced increases of almost 10% and payers expect brand name
drugs to continue to skyrocket ahead of other health spending. CT
ranks third highest among states in high-deductible health plans, meaning
that consumers are directly bearing the brunt of much of these rising costs.
The Cabinet’s recommendations
are now drafted and available
for public comment. They include sensible, feasible, and fair policy
options to promote value in healthcare spending, educate consumers and
providers about best practices, and control costs that are sacrificing
important spending in the state budget, employer and provider resources, and
family finances. Comments will be accepted until January 15th at
4:30pm. Submit comments to Victoria.veltri@ct.gov.
